Vaccine firm will get $400,000 from Indiana Seed Fund

Bioscience Vaccines will receive an investment of $400,000 from the Indiana Seed Fund, which was set up by BioCrossroads to help life sciences firms. Bioscience plans to put the money toward a technology that can be used to develop adjuvants, which can boost the efficacy of vaccines.

View Full Article in:

Indianapolis Star (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC